Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-09

Clinical Trial Update: Efficacy and Safety of DT01 Tablets in Patients With Irritable Bowel Syndrome With Diarrhea [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing the efficacy and safety of DT01 tablets in patients with irritable bowel syndrome with diarrhea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DT01

Snippet

Sponsor: Centre of Clinical Pharmacology, Hanoi Medical University | Conditions: Irritable Bowel Syndrome With Diarrhea | Phase 2 | Status: UNKNOWN